Seasonal, H1N1 flu vaccine to be combined this fall + Government to overhaul bioterror and pandemic flu plans

ANDREW W. GRIFFIN

Oklahoma Watchdog
August 19, 2010

OKLAHOMA CITY — For those concerned about the impending flu season, the government will be making the seasonal flu vaccine available again this year.

Except this year, there is a difference -the normal seasonal flu vaccine will be combined with swine flu (H1N1) vaccine as well.

“The 2010-2011 seasonal flu vaccine will include the H1N1 strain that was responsible for the 2009 pandemic,” said Vicki Monks, media spokesperson for the Oklahoma City-County Health Department.

Monks pointed to a February 2010 press release on the Flu.gov website that states: “Today’s recommendation to include protection against the 2009 H1N1 flu strain in next season’s flu vaccine was made by the FDA’s Vaccines and Related Biological Products Advisory Committee. The committee’s recommendations typically guide vaccine manufacturers in preparing each season’s flu vaccines. The World Health Organization has made the same recommendation.This recommendation will go into effect for next fall’s flu season. In the meantime, you can still protect yourself against the H1N1 flu by getting your H1N1 vaccine now.”

Read entire article

 

Government to overhaul bioterror and pandemic flu plans


 

Andrew Zajac
Los Angeles Times
August 20, 2010

The overhaul includes refinements to manufacturing aimed at shaving weeks off the time it takes to produce pandemic flu vaccine, and a series of steps aimed at more quickly spotting promising scientific discoveries and getting them to market.Acknowledging that the development of medical countermeasures against bioterrorism threats and pandemic flu is lagging, federal authorities Thursday announced a $1.9-billion makeover of the system for identifying and manufacturing drugs and vaccines for public health emergencies.

“We aren’t generating enough new products,” said Health and Human Services Secretary Kathleen Sebelius, citing “leaks, chokepoints and dead ends” in the medical development pipeline.

Read entire article


About this entry